Our Company
News & Latest Announcements
Latest News
Biosimilars on the Brink of Transformation: What EMA’s 2025 Vision and FDA Insights Mean for You
Are you ready for the next big shift in biosimilar development? The biosimilar landscape is evolving at lightning speed, driven by groundbreaking regulatory updates from the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA). The EMA’s 2025 reflection paper introduces a tailored clinical approach that promises to streamline biosimilar development, while...
Accelsiors at ASCO 2024: A Gateway to Collaboration and Innovation in Oncology
The recent American Society of Clinical Oncology (ASCO) conference served as a platform for Accelsiors to showcase our expertise, forge valuable connections, and reinforce our commitment to advancing cancer care and saving lives. The conference also provided opportunities for us to share our latest technological achievements and demonstrate our commitment to staying at the forefront...
Significant milestone in the golexanolone Phase 2 study!
We are happy to announce that the first two patients have been successfully randomized in the Phase 2 portion of the clinical trial evaluating golexanolone for the treatment of cognitive symptoms in Primary Biliary Cholangitis (PBC). This randomized, double-blind, placebo-controlled study aims to assess the efficacy of golexanolone in improving cognitive function, fatigue, and daytime...
Accelsiors at Bio Korea 2024
We’re still under the impact of Bio Korea 2024. This prestigious event brought together leading minds and organizations in biotechnology from around the world to discuss the future of innovation and global collaboration in the field. One of the key highlights was the “Smart Clinical Trial” session on the opening day, which focused on...
Swiss Biotech Day 2024: Exploring the Biotech Landscape
Accelsiors is pleased to present the key highlights of our participation in the highly anticipated Swiss Biotech Day 2024, which took place on April 22-23 at the Congress Center Basel in Switzerland. This event is renowned as one of Europe’s leading biotechnology conferences, serving as a crucial platform for industry professionals to connect, share ideas,...
